Videos

Analyst Moves: ACT, AMGN

Market News Video
|
April 02, 2013 AT 2:40 PM
Actavis (ACT) had its estimates and price target increased by Morgan Stanley (MS) as the generic Pulicort settlement should remove some uncertainty abou thte comopany. An overweight rating was issued with a price target of $101.